BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25214750)

  • 1. Genomics and personalized medicine:
    Chen LS; Bierut LJ
    J Food Drug Anal; 2013 Dec; 21(4):S87-S90. PubMed ID: 25214750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay of genetic risk factors (CHRNA5-CHRNA3-CHRNB4) and cessation treatments in smoking cessation success.
    Chen LS; Baker TB; Piper ME; Breslau N; Cannon DS; Doheny KF; Gogarten SM; Johnson EO; Saccone NL; Wang JC; Weiss RB; Goate AM; Bierut LJ
    Am J Psychiatry; 2012 Jul; 169(7):735-42. PubMed ID: 22648373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variants in the CHRNA5-CHRNA3-CHRNB4 Region of Chromosome 15 Predict Gastrointestinal Adverse Events in the Transdisciplinary Tobacco Use Research Center Smoking Cessation Trial.
    Culverhouse RC; Chen LS; Saccone NL; Ma Y; Piper ME; Baker TB; Bierut LJ
    Nicotine Tob Res; 2020 Feb; 22(2):248-255. PubMed ID: 30882151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined genetic influence of the nicotinic receptor gene cluster CHRNA5/A3/B4 on nicotine dependence.
    Lee SH; Ahn WY; Seweryn M; Sadee W
    BMC Genomics; 2018 Nov; 19(1):826. PubMed ID: 30453884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathways to precision medicine in smoking cessation treatments.
    Chen LS; Horton A; Bierut L
    Neurosci Lett; 2018 Mar; 669():83-92. PubMed ID: 27208830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CHRNA5/CHRNA3/CHRNB4 Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical Associations.
    Barrie ES; Hartmann K; Lee SH; Frater JT; Seweryn M; Wang D; Sadee W
    Hum Mutat; 2017 Jan; 38(1):112-119. PubMed ID: 27758088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markers in the 15q24 nicotinic receptor subunit gene cluster (CHRNA5-A3-B4) predict severity of nicotine addiction and response to smoking cessation therapy.
    Sarginson JE; Killen JD; Lazzeroni LC; Fortmann SP; Ryan HS; Schatzberg AF; Murphy GM
    Am J Med Genet B Neuropsychiatr Genet; 2011 Apr; 156B(3):275-84. PubMed ID: 21268243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation in the nicotinic acetylcholine receptor gene cluster CHRNA5-CHRNA3-CHRNB4 and its interaction with recent tobacco use influence cognitive flexibility.
    Zhang H; Kranzler HR; Poling J; Gelernter J
    Neuropsychopharmacology; 2010 Oct; 35(11):2211-24. PubMed ID: 20631687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholinergic receptor nicotinic alpha 5 subunit polymorphisms are associated with smoking cessation success in women.
    Tomaz PRX; Santos JR; Scholz J; Abe TO; Gaya PV; Negrão AB; Krieger JE; Pereira AC; Santos PCJL
    BMC Med Genet; 2018 Apr; 19(1):55. PubMed ID: 29621993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk gene variants for nicotine dependence in the CHRNA5-CHRNA3-CHRNB4 cluster are associated with cognitive performance.
    Winterer G; Mittelstrass K; Giegling I; Lamina C; Fehr C; Brenner H; Breitling LP; Nitz B; Raum E; Müller H; Gallinat J; Gal A; Heim K; Prokisch H; Meitinger T; Hartmann AM; Möller HJ; Gieger C; Wichmann HE; Illig T; Dahmen N; Rujescu D
    Am J Med Genet B Neuropsychiatr Genet; 2010 Dec; 153B(8):1448-58. PubMed ID: 20886544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene variance in the nicotinic receptor cluster (CHRNA5-CHRNA3-CHRNB4) predicts death from cardiopulmonary disease and cancer in smokers.
    Halldén S; Sjögren M; Hedblad B; Engström G; Hamrefors V; Manjer J; Melander O
    J Intern Med; 2016 Apr; 279(4):388-98. PubMed ID: 26689306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of variants in CHRNA5/A3/B4 gene cluster with smoking behaviors in a Korean population.
    Li MD; Yoon D; Lee JY; Han BG; Niu T; Payne TJ; Ma JZ; Park T
    PLoS One; 2010 Aug; 5(8):e12183. PubMed ID: 20808433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of Associations of CHRNA5-A3-B4 Genetic Variants with Smoking Cessation Treatment Outcomes in Caucasian Smokers despite Associations with Baseline Smoking.
    Tyndale RF; Zhu AZ; George TP; Cinciripini P; Hawk LW; Schnoll RA; Swan GE; Benowitz NL; Heitjan DF; Lerman C;
    PLoS One; 2015; 10(5):e0128109. PubMed ID: 26010901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHRNA3 rs1051730 and CHRNA5 rs16969968 polymorphisms are associated with heavy smoking, lung cancer, and chronic obstructive pulmonary disease in a mexican population.
    Pérez-Morales R; González-Zamora A; González-Delgado MF; Calleros Rincón EY; Olivas Calderón EH; Martínez-Ramírez OC; Rubio J
    Ann Hum Genet; 2018 Nov; 82(6):415-424. PubMed ID: 29993116
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Chaity NI; Apu MNH
    Heliyon; 2022 Jul; 8(7):e09947. PubMed ID: 35865987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pleiotropic effects of Chr15q25 nicotinic gene cluster and the relationship between smoking, cognition and ADHD.
    Schuch JB; Polina ER; Rovaris DL; Kappel DB; Mota NR; Cupertino RB; Silva KL; Guimarães-da-Silva PO; Karam RG; Salgado CAI; White MJ; Rohde LA; Grevet EH; Bau CHD
    J Psychiatr Res; 2016 Sep; 80():73-78. PubMed ID: 27302872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of CHRNA5-A3 genetic Locus variants and developing drug for chronic obstructive pulmonary disease.
    Lococo F; Cesario A; Petracca-Ciavarella L; Granone P; Russo P
    Curr Med Chem; 2012; 19(34):5863-70. PubMed ID: 23061658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoking Cessation Pharmacotherapy Based on Genetically-Informed Biomarkers: What is the Evidence?
    Panagiotou OA; Schuit E; Munafò MR; Bennett DA; Bergen AW; David SP
    Nicotine Tob Res; 2019 Aug; 21(9):1289-1293. PubMed ID: 30690475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Risk Can Be Decreased: Quitting Smoking Decreases and Delays Lung Cancer for Smokers With High and Low CHRNA5 Risk Genotypes - A Meta-Analysis.
    Chen LS; Baker T; Hung RJ; Horton A; Culverhouse R; Hartz S; Saccone N; Cheng I; Deng B; Han Y; Hansen HM; Horsman J; Kim C; Rosenberger A; Aben KK; Andrew AS; Chang SC; Saum KU; Dienemann H; Hatsukami DK; Johnson EO; Pande M; Wrensch MR; McLaughlin J; Skaug V; van der Heijden EH; Wampfler J; Wenzlaff A; Woll P; Zienolddiny S; Bickeböller H; Brenner H; Duell EJ; Haugen A; Brüske I; Kiemeney LA; Lazarus P; Le Marchand L; Liu G; Mayordomo J; Risch A; Schwartz AG; Teare MD; Wu X; Wiencke JK; Yang P; Zhang ZF; Spitz MR; Amos CI; Bierut LJ
    EBioMedicine; 2016 Sep; 11():219-226. PubMed ID: 27543155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review of genetic variation within nicotinic acetylcholine receptor genes and cigarette smoking cessation.
    Jones SK; Wolf BJ; Froeliger B; Wallace K; Carpenter MJ; Alberg AJ
    Drug Alcohol Depend; 2022 Oct; 239():109596. PubMed ID: 35981468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.